Dear Travellers, Travel & Media Partners,
In the wake of the outbreak of the 2019 novel coronavirus (COVID-2019), we would like to bring to your attention the latest updates on the travel situation in Malaysia:
Dear Friends of Malaysia,
Malaysia is ready to allow fully-vaccinated international tourists to visit Langkawi in a pilot project for a minimum stay of three days with no quarantine restrictions starting 15 November 2021. However, international tourists must undergo COVID-19 RT-PCR testing 72 hours before departure. They need to bring along a digital or printed copy of their results and have the MySejahtera app downloaded before departure.
International tourists to Langkawi must also have minimum insurance of US$80,000 and engage in tourism services licensed by the Ministry of Tourism, Arts and Culture (MOTAC). Children under the age of 18 must be accompanied by fully-vaccinated parents or guardians.
Tourists arriving via Kuala Lumpur International Airport (KLIA) would be subjected to Rapid Molecular Testing, while those heading directly to Langkawi must undergo an RT-PCR test on the second day after arrival. Only a maximum of 20 people in a group tour is allowed with a tourist guide per group.
International tourists staying more than five days must undergo an RT-PCR test on day five. However, those visiting for three days may use the COVID-19 screening test on the second day to depart to their home country.
This International Tourism Bubble (Inbound) pilot project will run for three months and is open to travellers from countries approved by the Foreign Affairs Ministry, Health Ministry and the Immigration Department.
As of 25 October 2021, Malaysia has fully vaccinated 94.7% of its adult population or 73.2% of its total population, with 81.6% of teenagers aged between 12 and 17, received at least one dose of the COVID-19 vaccines.
Malaysia has also started to offer booster doses voluntarily to the high-risk groups, including frontline workers and senior citizens, especially for those who have completed their two doses of the Pfizer BioNTech vaccine (Comirnaty) for at least six months besides administering heterologous booster shots to those who have completed both doses of Sinovac vaccine for at least three months.
Meanwhile, all Malaysian states are currently either in Phase 3 or Phase 4 in the country’s four-phase of National Recovery Plan, which both allow the resumption of most economic activities.
As of 25 October 2021, another 7,414 COVID-19 patients have recovered, and at the same time, Malaysia recorded 4,782 new cases, totalling 2,436,498 cases nationwide. The country’s COVID-19 death toll is 28,492.